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Testicular microlithiasis (TM) is characterised by small intratesticular calcifications, which can be visualised by ultrasound. Men with
testicular germ cell tumour (TGCT) have a higher frequency of TM than men without TGCT. To clarify the association between
TGCT and TM and to investigate the relationship between TGCT susceptibility and TM, we recruited TGCT patients with and
without family history of TGCT, unaffected male relatives and healthy male controls from the UK. Testicular ultrasound data were
analysed from 328 men. Testicular microlithiasis was more frequent in TGCT cases than controls (36.7 vs 17.8%, age adjusted
Po0.0001) and in unaffected male relatives than controls (34.5 vs 17.8%, age adjusted P¼0.02). Testicular germ cell tumour case and
matched relative pairs showed greater concordance for TM than would be expected by chance (P¼0.05). We show that TM is
present at a higher frequency in relatives of TGCT cases than expected by chance indicating that TM is a familial risk factor for TGCT.
Although the familiality of TM could be due to shared exposures, it is likely that there exists a genetic susceptibility to TM that also
predisposes to TGCT. We suggest that TM is an alternative manifestation of a TGCT susceptibility allele.
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Testicular germ cell tumour (TGCT) is the most common
cancer in men aged 15–45 years. Risk factors for TGCT
include a family history of disease (Forman et al, 1992;
Westergaard et al, 1996; Heimdal et al, 1996a; Sonneveld et al,
1999; Hemminki and Li, 2004), a previously diagnosed germ
cell tumour (Osterlind et al, 1991; Wanderas et al, 1997), a history
of undescended testis (Brown et al, 1987; Swerdlow et al, 1997),
infertility (Petersen et al, 1998; Moller and Skakkebaek, 1999;
Jacobsen et al, 2001; Richiardi et al, 2004), atrophy (Harland et al,
1998), and gonadal dysgenesis (Verp and Simpson, 1987).
In a proportion of cases (B2%), a first-degree family member
is also affected with the disease (Forman et al, 1992). The
relative risk to a brother of a TGCT case is 8–10 (Forman et al,
1992; Heimdal et al, 1996b; Hemminki and Li, 2004), which is
higher than for most other cancer types that rarely exceed four
(Dong and Hemminki, 2001) and suggests that predisposition
genes are important in this disease. However, despite intensive
efforts, susceptibility genes are yet to be identified (Crockford
et al, 2006).
Testicular microlithiasis (TM), the presence of multiple small
deposits of calcium within the testis, shows characteristic
sonographic findings of multiple, intratesticular, nonshadowing
echogenic foci. Since the original description of ultrasound-
detected TM (Doherty et al, 1987), a number of studies have
reported an association between TGCT and TM (Backus et al, 1994;
Miller et al, 1996, 2006; Cast et al, 2000; Bach et al, 2001;
Bennett et al, 2001; Derogee et al, 2001; Middleton et al, 2002;
Sakamoto et al, 2006). All the studies report ultrasound
findings for men investigated for a suspect testicular pathology
(infertility, hydrocele, varicocele or suspected tumour) and
compare the rate of TM in men found to have TGCT with those
that have other diagnoses, including normal testes. The studies
have shown a high frequency of TM associated with TGCT (range
12–74%) compared to 0.68–9% for other diagnoses (Rashid et al,
2004). No study has compared TGCT cases to control subjects
without suspected testicular pathology. Two studies that examined
the prevalence of TM among non-symptomatic army recruits
(median age at ultrasound of 18–20 years) showed approximately
6% had TM (defined as X5 microliths) (Peterson et al, 2001; Serter
et al, 2006).
Although previous data suggest that TM is a risk factor
for TGCT, the frequency of TM in relatives of TGCT patients
has never been examined. Furthermore, the familiality of TM
itself has not previously been investigated. Given that the
relationship of TM to the well-documented familial risk of
TGCT is unknown, we investigated the frequency of TM among
TGCT cases, their male relatives and healthy male controls
to evaluate the hypothesis that TM is a familial risk factor
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TM.
MATERIALS AND METHODS
Participants
Cases of TGCT were identified from the Royal Marsden Hospital
testicular cancer clinic, Sutton, Surrey, UK and from a national UK
study of familial testicular cancer coordinated at the Institute of
Cancer Research (ICR). All TGCT cases were unrelated. In cases
with a family history of TGCT, the affected relative(s) were not
recruited. All cases had a prior diagnosis of germ cell tumour and
were diagnosed between 1973 and 2005. Tumour histology was
confirmed from pathology reports or medical notes. Each case was
asked to nominate an unaffected relative (preferably first degree)
to participate in the study and a friend or in-law to act as a control
subject. To prevent intrafamilial correlation, only one unaffected
relative per TGCT case was recruited. Additional controls were
identified by approaching local sporting clubs and by a call for
volunteers at the ICR. Only patients of white Caucasian ancestry
were included in this analysis. All men participated with fully
informed consent and local ethical review board approval.
Procedures
Study participants attended a research clinic prior to which they
were asked to complete a family history questionnaire and a
medical history questionnaire. These documents were reviewed at
the research clinic. In addition, height, weight, BMI, percentage
body fat and blood pressure were recorded.
Testicular ultrasound scans were carried out on both testes in
men without previous orchidectomy, on the solitary remaining
testis in those with a previous unilateral orchidectomy and on
residual testicular tissue in those men with bilateral tumours who
had undergone initial orchidectomy and subsequent contralateral
partial orchidectomy. All scans were carried out by a single
sonographer (EP) using 15–17.5MHz linear array probes (Philips
iU 22 system; Koninklijke Philips Electronics NV and ATL HDI
system, Bothell, WA, USA). Images were stored on a hard drive
and all clinically significant findings were checked by a consultant
radiologist (AS) who also double-read scans at the beginning of the
study as a quality assurance measure. Ultrasound was performed
in a semiblinded manner. The sounographer was aware if the
research participant had a previous germ cell tumour and
orchidectomy but was unaware if the TGCT case had a family
history of disease or not. For all other research participants, the
sounographer was not aware if the participant was an unaffected
male relative of a TGCT case or a healthy male control. For each
examinable testis, TM was counted, categorised and recorded as
shown in Table 1, based on the model described by Backus et al,
(1994). We performed analyses based on any TM (X1 microlith
in a testes) also described as Limited TM (LTM) and on TM X5
microliths per testes, referred to as Classical TM (CTM)
(Middleton et al, 2002).
Statistical analysis
Participants were categorised into three groups; TGCT case
(cases), unaffected male relative of a TGCT case (relatives) and
healthy male volunteers with no known family history of TGCT
(controls). For more detailed analysis, the first two groups were
subclassified as follows: TGCT-FH (family history), an index case
with a germ cell tumour and at least one other affected male
relative with the disease; TGCT-S (sporadic), an index case with a
germ cell tumour and no known family history of the disease;
relative-FH, an unaffected male relative of a TGCT-FH case (i.e. a
participant with at least two affected male relatives); relative-S, an
unaffected male relative of a TGCT-S case (i.e. with only one
affected male relative) (Table 2).
Mean age at ultrasound was calculated for each of the three
groups and compared by t-test. Differences in TM frequency
among study groups were compared using unconditional logistic
regression, adjusting for age as a continuous covariate. Con-
cordance for TM among matched relative pairs was tested using
the Pearson w
2 test. All statistical analyses were carried out using
STATA (StataCorp. 2005. Stata Statistical Software: Release 9.
College Station, TX: StataCorp LP).
RESULTS
Between June 2004 and June 2006, 328 men consented, were
examined by ultrasound and included in the data analysis. Of
these, 169 were cases, 58 were relatives, and 101 were controls
(Table 2). Forty-eight TGCT cases had a relative who participated
in the study (26 (54.2%) brothers, 7 (14.5%) fathers, 13 (27.1%)
sons, 1 (2.1%) maternal uncle and 1 (2.1%) nephew). For 10
relatives, there was no matching case available for analysis. The
reasons were: in four relatives, the case had bilateral disease and
therefore did not have testes available for ultrasound; in two
relatives, the case was deceased; and in four relatives, the case
consented to the study but failed to attend the research clinic.
A total of 493 testes in 328 men were examined by ultrasound.
Of 169 cases, 162 had only one testis available for ultrasound
examination. Four cases had bilateral disease and had undergone a
standard total orchidectomy for the first tumour. In two of these
cases, the second tumour was diagnosed as CIS at biopsy and both
patients were treated without contralateral orchidectomies; ultra-
sound was performed on the remaining testes. The other two
patients with bilateral disease had a contralateral partial orchi-
dectomy and the remaining testicular tissue was examined by
ultrasound. Seven cases did not have orchidectomies (five with
extragonadal germ cell tumours without clear gonadal primaries
and two patients treated for metastatic disease without orchidectomy),
both testes were examined by ultrasound in these seven cases. Of
58 relatives, one participant had a history of testicular torsion and
orchidectomy; all other relatives had both testes available for
analysis. No orchidectomies were reported in the 101 controls
(Table 2). The mean age of the controls was significantly lower (42)
than that of the cases (47) (P¼0.0003, t-test) and approached
significance with the unaffected relatives (45) (P¼0.14, t-test);
there was no age difference between the cases and their relatives
(P¼0.3, t-test).
A total of 173 tumours were reported in the 169 cases as four
patients had a second tumour (two seminomas and two CIS).
Tumour histology for the first tumour is given in Table 3. A total of
41 (24.0%) cases had a documented family history of TGCT. The
mean age of diagnosis was 34 years for cases both with and without
a family history (Table 3). The median time between TGCT
diagnosis and research ultrasound was 12 years (range 1–32).
Testicular microlithiasis (X1 microlith in any testis) was more
frequent in cases than controls, 62/169 (36.7%) vs 18/101 (17.8%),
odds ratio (OR) 3.0 (95% CI 1.6–5.6), age adjusted Po0.0001. The
frequency in unaffected male relatives (20/58, 34.5%) was also
Table 1 Classification of TM
Group Number of microliths per testis
None 0
Limited 1–4
Scant 5–24
Moderate X25 but without areas of confluence
Too numerous to count X25 and with areas of confluence
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Study group
Number of men
examined by
ultrasound
Mean age at
ultrasound
(range)
Surgery for
undescended
testis
Both testis
examined
One testis
examined
One testis
examined with
previous CIS or
malignancy
Number of
testes examined
TGCT Cases 169 47 (25–78) 21 7 158 4 176
Subgroup A: TGCT-FH 41 47 (25–68) 3 1 39 1 42
Subgroup B: TGCT-S 128 47 (26–78) 18 6 119 3 134
Relatives 58 44 (18–74) 2 57 1 0 115
Subgroup C: Relative-FH 24 41 (18–74) 2 24 0 0 48
Subgroup D: Relative-S 34 46 (19–70) 0 33 1 0 67
Control 101 42 (20–74) 2 101 0 0 202
Total 328 25 165 159 4 493
FH¼family history; S¼sporadic.
Table 3 First tumour histology for index TGCT cases
TGCT-FH TGCT-S All cases
Number of
cases
% known
histology
Mean age at
diagnosis
Number of
cases
% known
histology
Mean age at
diagnosis
Number of
cases
% known
histology
mean age at
diagnosis
Seminoma 21 51.2 37 55 43.3 39 76 45.2 38
Non-seminoma 20 48.8 31 72 56.7 31 92 54.8 31
Unknown 0 — 1 — 20 1 — 20
Total 41 — 34 128 — 34 169 — 34
Percentage given for known histology.
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Molecular Diagnosticshigher than that in controls (OR 2.5, 95% CI 1.2–5.4, age adjusted
P¼0.02). The proportion of cases and relatives with TM was not
significantly different. However, the number of testes available for
study in the relative group is double that of the cases. Comparing
the testis examined in cases with the same testis in the matched
relative, 48 cases had assessable testis of which 18/48 (37.5%) had
TM and 11/48 (22.9%) relatives matched testes had TM (Pp0.2).
For the 48 families with a case and a relative, 10 pairs were
concordant for the presence of TM, 22 were concordant for the
absence of TM and 16 were discordant (P¼0.05 for independence)
showing that TM diagnosis aggregates in families. To determine if
the familial aggregation was likely to be due to shared environ-
mental or shared genetic factors, we evaluated the proportion of
brother pairs and other relative pairs in the concordant/discordant
TM groups. Of the TM concordant series, 6 were brother pairs
(60%); in the discordant set, 11 (69%) were brothers and in the no
TM concordant set, 9 (41%) brothers (P¼0.22 for equal
distribution between brother and other relative pairs).
The frequency of TM in TGCT cases with a family history of
TGCT compared with cases with no family history was 18/41
(43.9%) vs 44/128 (34.4%); age adjusted P¼0.3. The frequency of
TM in men with two or more relatives with TGCT than men with
only one affected relative was 11/24 (45.8%) vs 9/34 (26.5%); age
adjusted P¼0.1 (Table 4).
The frequency of bilateral TM was not different between
relatives and controls with TM (8/20 (40.0%) vs 8/18 (44.4%),
P¼0.8). The severity of TM was greater in cases and relatives than
for controls. A total of 83/101 (82%) of controls had no TM, 12
(12%) had LTM and 6 (6%) had CTM. In comparison, 145/227
(64%) of cases and relatives combined had no TM, 39 (17%) had
LTM and 43 (19%) had CTM (w
2¼12.54, P trend¼0.0004).
There was no difference in the distribution of histological types
between TGCT cases with and without TM. In cases with TM,
46.7% were diagnosed with a seminoma and 53.2% with non-
seminoma; in cases without TM, 44.3% were diagnosed with
seminoma and 55.6% with non-seminoma.
Of the four patients with bilateral TGCT and an assessable testis,
both patients with biopsy-proven CIS in the contralateral testis
showed TM (one LTM and one scant TM). In the two patients who
had undergone partial orchidectomy, one had LTM in the
remaining portion of the testis and the second had no TM. Of
the seven TGCT cases with two assessable testes, bilateral TM was
documented in one case, who had a metastatic seminoma treated
without orchidectomy (Table 3). In the five patients with
extragonadal GCT treated without orchidectomies, four had
unilateral LTM.
Two tumours were diagnosed in the course of the study. A
brother of a TGCT-S case showed bilateral LTM and a lesion that
was suspected to be a tumour on ultrasound. Orchidectomy
revealed a classical seminoma. The second tumour was diagnosed
in an index TGCT-S case. This patient was treated for metastatic
disease without orchidectomy 15 years prior to the study and
showed no TM on ultrasound but a calcified lesion in the left testis.
Orchidectomy revealed a non-seminoma.
DISCUSSION
We show for the first time that TM is more frequent in unaffected
male relatives of TGCT cases than in healthy male controls. We
also demonstrate that patients with a history of TGCT have a
higher frequency of TM in their contralateral remaining testis than
controls, supporting previous data that suggest an association
between TGCT and TM. The higher frequency of TM in unaffected
male relatives of TGCT cases than controls indicates that the
association between TM and TGCT is not simply a consequence of
the development or treatment of the testicular tumour. We have
also demonstrated significant concordance of TM between
relatives. The familial aggregation raises the hypothesis that TGCT
and TM have a joint aetiology.
Our findings appear to be independent of the classification of
TM. Many studies in the literature limit reports of TM to five or
more microcalcifications (CTM). However, this cutoff is arbitrary
and studies, which include LTM (one to four microcalcifications)
also demonstrate an association with TGCT (Bennett et al, 2001;
Middleton et al, 2002). For these reasons, we decided to count and
analyse all TM (X1 microlith per testes) in this study. Therefore,
the frequency of TM we report for healthy male participants is
higher than in some previous studies, which report TM as X5
microliths per testes (CTM) (Peterson et al, 2001; Serter et al,
2006). However, if we limit the definition of TM to X5 microliths,
the frequency of CTM is similar to other analyses of asymptomatic
men at 6/101 (5.9%). Furthermore, if we apply this limit to all the
data, the rate of CTM in TGCT cases is 32/169 (18.9%), for relatives
is 11/58 (19.0%) and the differences between the cases and controls
(18.7 vs 5.9%, age adjusted P¼0.002) and relatives and controls
(19 vs 5.9%, age adjusted P¼0.01) remain statistically significant.
The familial clustering of TM demonstrated in this study
could be due to shared environmental or shared genetic factors
between relatives. Environmental factors, which may be involved
in the genesis of TGCT are widely believed to occur in utero
or in early childhood. We see concordance for TM in a variety of
relative pairs, including father/son and son/father pairs and
therefore prenatal environmental exposure is unlikely to account
for the familial effect. Moreover, we do not show an excess of
brother pairs in the TM concordant group, which we may have
expected if the familiarity of TM was due to a shared environ-
mental effect.
Table 4 Testicular microlithiasis detected per study group
Unilateral TM Bilateral TM
a
Study
group Subgroup No TM Limited Scant Moderate TNTC Limited Scant Moderate TNTC
Total TM/total
cases (% TM/group)
Cases 107 30 15 9 7 0 1 0 0 62/169 (36.7)
TGCT-FH 23 6 5 3 3 0 1
b 0 0 18/41 (43.9)
TGCT-S 84 24 10 6 4 0 0 0 0 44/128 (34.4)
Relatives 38 8 3 0 0 1 5 2 1 20/58 (34.5)
Relative-FH 13 4 1 0 0 1 3 1 1 11/24 (45.8)
Relative-S 25 4 2 0 0 0 2 1 0 9/34 (26.5)
Control 83 9 1 0 0 3 2 2 1 18/101 (17.8)
TNTC¼to numerous to count.
aTM detected in both testes, highest degree of TM scored.
bThe patient presented with metastatic seminoma and was treated with
chemotherapy and radiotherapy alone. He had limited TM of the right testis and scant TM in the left. The testicular primary was never established in this patient.
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observations suggest that TM overlaps with TGCT susceptibility
and that TM may be, at least in part, genetically determined. This
is the first time such an observation has been made and suggests
that TGCT susceptibility alleles may give rise to additional clinical
phenotypes such as TM. However, in addition to the above, we
would have expected that cases with a family history of TGCT
would have a higher incidence of TM than cases without a family
history. Similarly, we would have expected that relatives with
familial TGCT would have a higher incidence of TM than those
relatives with only one case in the family. While numerically this
was the case in our study, the difference was not statistically
significant. The small numbers of matched case–relative pairs in
the analysis may have accounted for this and an additional larger
series would be required to confirm this trend.
As with all studies that recruit volunteers as controls, there is a
potential for bias. However, in this study, 56% of controls were
nominated by previous research participants, usually a friend or
unrelated relative (e.g. brother-in-law), and then approached to
enter the study, thus limiting this effect. The remainder of the
control group was derived from volunteers. As demonstrated, the
overall rate of CTM among healthy controls in our study is similar
to that reported previously (Peterson et al, 2001; Serter et al, 2006).
Furthermore, there was no difference in the rate of TM reported
between the two control sources (8/57 (14%) vs 10/44 (22.7%),
w
2(1)¼1.3, P¼0.3). Interestingly, the frequency of CTM in our
control population with a mean age of 42 years reflects that of the
younger asymptomatic populations evaluated. This would suggest
that frequency of TM does not change with age.
The study does not determine the temporal trends of TM. We
examined the frequency of TM in the contralateral testis in
patients with a previously diagnosed tumour; however, we did not
have access to the original diagnostic ultrasound reports for
comparison. Therefore, we cannot determine if the TM demon-
strated in the contralateral testis was present at diagnosis.
Our study, similar to other studies that have investigated the
association of TGCT with TM, does not show that TM is a pre-
invasive lesion and additional longitudinal studies are required to
determine if any of our participants with TM are subsequently
diagnosed with TGCT.
In conclusion, we not only demonstrate that TM is more
frequent in TGCT cases than controls, but importantly show that
TM is more frequent in unaffected male relatives of TGCT cases.
This would suggest that TM is a familial risk factor for TGCT and
may have a joint aetiology. Furthermore, we demonstrate that TM
aggregates in families, suggesting a common genetic susceptibility
to TGCT. This may have implications for mapping and identifica-
tion of TGCT genes.
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